Brief: Nasdaq Decides To Delist Novakand From First North Growth Market
26/03/2026 10:47
March 26 (Reuters) - Novakand Pharma AB NOVKAN.ST: NASDAQ DECIDES TO DELIST NOVAKAND FROM FIRST NORTH GROWTH MARKET SHARES CAN BE TRADED UNTIL APRIL 13, 2026 BOARD INTENDS TO CALL EXTRAORDINARY GENERAL MEETING FOR NEW BUSINESS DIRECTION AND LISTING PLAN Source text: ID:nMFNbd76Ts Further company coverage: NOVKAN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing